男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Economic rebound prompts investment, new goals for foreign multinationals

By Ma Si,Zhong Nan and Zheng Xin | CHINA DAILY | Updated: 2023-03-13 07:31
Share
Share - WeChat
A hair show is held at the Shanghai Stadium by L'Oreal Paris Pro on March 2. [Photo/China News Service]

Companies from overseas say they are looking forward to continuing their profitable relationships with the Chinese market. Ma Si, Zhong Nan and Zheng Xin report.

China's steady economic rebound, encouraging signals and efficient policies introduced during the two sessions are boosting confidence among multinational companies operating in the country.

Believing that China's growth this year will outrun most major economies, despite headwinds, executives said they are seeing many more opportunities in areas such as healthcare, consumption, advanced manufacturing and innovation-driven development.

Eager to turn those prospects into reality, foreign companies are ramping up investment, expanding their business lines and chalking up medium-to-long-term plans for steady growth with a rosy view of China's high-quality economic upgrade in the coming years.

Ulrich Stefer, chief financial officer of Bayer Group Greater China, said: "China, without any doubt, will play a crucial role in impacting global growth this year as the world's second-largest economy. We notice that various international financial institutions and investment banks have raised their predictions for China's economic growth this year."

Highlighting the country's massive market, sophisticated industrial system, strong supply chain competitiveness and the improving business environment, Stefer said, "The Chinese market remains extremely attractive on a far-reaching level for multinational companies, including Bayer, to join and expand their investment."

He added that the multimillion dollar expansion project of Bayer's Beijing pharmaceuticals plant will be completed this year. The plant is expected to boost the company's production capacity for prescription drugs by 40 percent and greatly improve its ability to meet the medical needs of Chinese patients.

1 2 3 4 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 曲阳县| 屏山县| 社旗县| 乐至县| 江西省| 旬阳县| 行唐县| 泽州县| 抚州市| 呼图壁县| 玉龙| 宜兴市| 江西省| 吉木乃县| 息烽县| 古丈县| 祁东县| 兴隆县| 永年县| 吴江市| 唐海县| 镇安县| 桃源县| 辰溪县| 平顶山市| 安西县| 黎川县| 股票| 庆云县| 大余县| 通渭县| 双城市| 剑川县| 温宿县| 阜南县| 永春县| 札达县| 南阳市| 文化| 会东县| 金川县|